Susquehanna Fundamental Investments’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.56M Sell
2025
Q1
$2.39M Buy
2023
Q2
Sell
2023
Q1
$579K Hold
2022
Q4
$665K Buy
2022
Q3
$415K Buy